Consist with the previous study, treatment with downregulation of DKK-3 facilitated malignant phenotypes of prostate cancer cells, upregulating MMP-2 and MMP-9, and even reversed the effect caused by overexpression of LINC00261. This evidence concerns the gene MMP9 and Familial prostate cancer.